Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis

Completed · Phase 3 · Has a placebo group

Conditions studied: Pruritus, Prurigo Nodularis

In brief

Study of the efficacy, safety, and tolerability of serlopitant for the treatment of pruritus in adults with prurigo nodularis

Key facts

Study ID
NCT03546816
Run by
Vyne Therapeutics Inc.
People needed
285
Starts
2018-05-02
Expected to finish
2020-02-14
Last updated by the study team
2021-05-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.